NEW YORK, October 30, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Caterpillar Inc. (NYSE: CAT), The Boeing Company (NYSE: BA), United Technologies Corporation (NYSE: UTX), Precision Castparts Corp. (NYSE: PCP) and Martin Marietta Materials Inc. (NYSE: MLM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7559-100free.

-- Caterpillar Inc. Research Reports On October 23, 2014, Caterpillar Inc. (Caterpillar) announced its Q3 2014 financial results. The Company's Q3 2014 sales and revenue remained nearly flat at $13.5 billion on a year-on-year basis. Caterpillar reported that total sales volume during the quarter fell $187 million as a result of lower end-user demand primarily for mining equipment, as customers continued to reduce their capital expenditures. Geographically, the Company's sales increases in North America were about offset by declines in Latin America and Asia-Pacific. Caterpillar's net income during the quarter increased to $1.0 billion or $1.63 per diluted share, from $946 million or $1.45 per diluted share in Q3 2013. Analysts, on average, expected Caterpillar to earn $1.36 per share on sales of $13.2 billion, according to Reuters. Looking ahead, the Company now expects to earn $6.50 per share, excluding restructuring costs, in full-year 2014, compared to the previous forecast of $5.85 per share. The full research reports on Caterpillar are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/CAT/report.pdf

-- The Boeing Company Research Reports On October 27, 2014, The Boeing Company's (Boeing's) Chairman and CEO, Jim McNerney, reported that the Board of Directors of the Company has declared a regular quarterly dividend of $0.73 per share. The dividend is payable on December 5, 2014, to shareholders of record as of November 7, 2014. The full research reports on Boeing are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/BA/report.pdf

-- United Technologies Corporation Research Reports On October 21, 2014, United Technologies Corporation (UTC) announced its Q3 2014 financial results. The Company's net sales during the quarter increased 4.6% YoY to $16.2 billion, all driven by organic growth. UTC's net income attributable to common shareholders increased to $1.9 billion, or $2.04 per diluted share, from $1.4 billion or $1.55 per diluted share in Q3 2013. Excluding one-time items, the Company reported that it earned $1.82 per share in Q3 2014, beating the average estimate of $1.81 in a Reuters poll of analysts. "With double-digit earnings and 4 percent organic sales growth through the first three quarters, UTC remains on track to deliver on our expectations for the year," said Louis Chenevert, UTC Chairman & CEO. "Our solid backlog and organic growth trends continue to give us confidence in our earnings per share range of $6.75 to $6.85, on sales of about $65 billion." The full research reports on UTC are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/UTX/report.pdf

-- Precision Castparts Corp. Research Reports On October 23, 2014, Precision Castparts Corp. (PCC) announced its Q2 FY 2015 financial results (period ended September 28, 2014). PCC's net sales during the quarter rose 7.7% YoY to $2.5 billion. Organic sales growth was approximately 4% compared to last year, excluding the impact of metal/revert pricing. Net income attributable to the Company increased to $467 million, or $3.24 per diluted share, in Q3 2014 as compared to $424 million or $2.89 per diluted share in Q3 2013. Analysts polled by Thomson Reuters expected the Company to report earnings of $3.32 per share for the quarter. PCC said that a full quarter of results from recent acquisitions, Permaswage and Aerospace Dynamics International, had a positive impact on second quarter sales and earnings, compared to the same period a year ago. The full research reports on PCC are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/PCP/report.pdf

-- Martin Marietta Materials Inc. Research Reports On October 27, 2014, the stock of Martin Marietta Materials, Inc. (Martin Marietta) closed at $120.62, down 1.88%, a day ahead of the release of its Q3 2014 financial results. The Company's stock opened at $121.13, and fluctuated in the range of $119.39 - $121.56, with a total of 1.61 million shares changing hands. Over the last one month, the Company's stock has declined by 7.73%, compared to the S&P 500 index which fell 1.07% during the same period. The full research reports on Martin Marietta are available to download free of charge at:

http://www.analystsreview.com/Oct-30-2014/MLM/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review